Related Experiment Video
Updated: Jun 3, 2026
08:08
Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta
Published on: June 10, 2015
[Nitric oxide donors activated by two-photon excitation]
Kazuhiro Hishikawa1, Hidehiko Nakagawa, Naoki Miyata
1Graduate School of Pharmaceutical Science, Nagoya City University.
Summary
Researchers developed advanced nitric oxide (NO) donors for controlled biological release. These photoactivatable compounds overcome limitations of existing NO delivery methods, enabling precise temporal and spatial NO application in biological studies.
Area of Science:
- Chemistry
- Biomedical Engineering
- Photochemistry
Background:
- Nitric oxide (NO) is vital for physiological processes like blood pressure regulation and immune response.
- Existing NO donors often lack controlled release, complicating biological applications.
- Current photoactivatable NO donors typically absorb UV or visible light, limiting tissue penetration.
Purpose of the Study:
- To review photocontrollable nitric oxide (NO) donors.
- To discuss the properties and biological applications of novel two-photon excitation (TPE) NO donors.
- To highlight advancements in controlled NO delivery for biological research.
Main Methods:
- Development of TPE-type NO donors based on 2,6-dimethylnitrobenzene derivatives.
- Investigation of NO release properties triggered by photoexcitation.
- Review of existing literature on photocontrollable NO donors and TPE-based systems.
Main Results:
- Novel TPE NO donors offer improved spatial and temporal control over NO release.
- These donors utilize longer wavelength light, enhancing tissue penetration compared to UV/visible light activators.
- Fe-nitrosyl complexes and nitrobenzene derivatives represent key platforms for TPE NO donor development.
Conclusions:
- Photocontrollable NO donors, particularly those activated by TPE, provide significant advantages for biological applications.
- Advanced NO donor design is crucial for overcoming limitations in NO delivery for therapeutic and research purposes.
- Future research should focus on optimizing TPE NO donors for enhanced efficacy and broader biological implementation.
More Related Videos
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...